Medicover Valuation
| 5M0B Stock | EUR 15.14 0.16 1.05% |
At this time, the firm appears to be fairly valued. Medicover AB secures a last-minute Real Value of €15.64 per share. The latest price of the firm is €15.14. Our model forecasts the value of Medicover AB from analyzing the firm fundamentals such as Current Valuation of 2.94 B, profit margin of 0.01 %, and Return On Equity of 0.0261 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Medicover's price fluctuation is very steady at this time. Calculation of the real value of Medicover AB is based on 3 months time horizon. Increasing Medicover's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medicover stock is determined by what a typical buyer is willing to pay for full or partial control of Medicover AB. Since Medicover is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medicover Stock. However, Medicover's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 15.14 | Real 15.64 | Hype 15.14 | Naive 15.74 |
The real value of Medicover Stock, also known as its intrinsic value, is the underlying worth of Medicover AB Company, which is reflected in its stock price. It is based on Medicover's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Medicover's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Medicover AB helps investors to forecast how Medicover stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medicover more accurately as focusing exclusively on Medicover's fundamentals will not take into account other important factors: Medicover Total Value Analysis
Medicover AB is presently estimated to have takeover price of 2.94 B with market capitalization of 2.54 B, debt of 375.8 M, and cash on hands of 55.9 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Medicover fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.94 B | 2.54 B | 375.8 M | 55.9 M |
Medicover Investor Information
About 13.0% of the company shares are owned by insiders or employees . The book value of Medicover was presently reported as 3.19. The company last dividend was issued on the 28th of April 2023. Based on the analysis of Medicover's profitability, liquidity, and operating efficiency, Medicover AB is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Medicover Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Medicover has an asset utilization ratio of 81.78 percent. This implies that the Company is making €0.82 for each dollar of assets. An increasing asset utilization means that Medicover AB is more efficient with each dollar of assets it utilizes for everyday operations.Medicover Ownership Allocation
Medicover AB maintains a total of 71.58 Million outstanding shares. 30% of Medicover outstanding shares are owned by institutional investors. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Medicover Profitability Analysis
The company reported the revenue of 1.38 B. Net Income was 101.8 M with profit before overhead, payroll, taxes, and interest of 339.4 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Medicover's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Medicover and how it compares across the competition.
About Medicover Valuation
The stock valuation mechanism determines Medicover's current worth on a weekly basis. Our valuation model uses a comparative analysis of Medicover. We calculate exposure to Medicover's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Medicover's related companies.Medicover AB provides diagnostic and healthcare services in Germany, Romania, Ukraine, Poland, Belarus, Moldova, Serbia, Turkey, Georgia, Bulgaria, India, and Hungary. Medicover AB was founded in 1995 and is headquartered in Stockholm, Sweden. MEDICOVER operates under Health Care Plans classification in Germany and is traded on Frankfurt Stock Exchange. It employs 20970 people.
8 Steps to conduct Medicover's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Medicover's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Medicover's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Medicover's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Medicover's revenue streams: Identify Medicover's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Medicover's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Medicover's growth potential: Evaluate Medicover's management, business model, and growth potential.
- Determine Medicover's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Medicover's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Medicover Stock analysis
When running Medicover's price analysis, check to measure Medicover's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicover is operating at the current time. Most of Medicover's value examination focuses on studying past and present price action to predict the probability of Medicover's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicover's price. Additionally, you may evaluate how the addition of Medicover to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |